Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice.
about
Hepatitis B virus regulatory HBx protein binds to adaptor protein IPS-1 and inhibits the activation of beta interferonViral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral responseCrosstalk between innate and adaptive immunity in hepatitis B virus infectionThe Molecular and Structural Basis of HBV-resistance to Nucleos(t)ide AnalogsRNase L plays a role in the antiviral response to West Nile virus.Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons.Double-stranded RNA-activated protein kinase regulates early innate immune responses during respiratory syncytial virus infectionImmunology of hepatitis B virus and hepatitis C virus infectionGenomic analysis of the host response to hepatitis B virus infection.Alpha/beta interferon differentially modulates the clearance of cytoplasmic encapsidated replication intermediates and nuclear covalently closed circular hepatitis B virus (HBV) DNA from the livers of hepatocyte nuclear factor 1alpha-null HBV transgEffects of interferon-α/β on HBV replication determined by viral load.Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virusGenomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells.Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathwaysTransforming growth factor-β1 suppresses hepatitis B virus replication by the reduction of hepatocyte nuclear factor-4α expression.Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection.Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes.Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis BQuantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy.Regulation of hepatocyte fate by interferon-γ.miR-23a targets interferon regulatory factor 1 and modulates cellular proliferation and paclitaxel-induced apoptosis in gastric adenocarcinoma cells.Association between IL28B polymorphisms and spontaneous clearance of hepatitis B virus infection.Strain-dependent requirement for IFN-γ for respiratory control and immunotherapy in murine gammaherpesvirus infectionMolecular viral oncology of hepatocellular carcinoma.Role of IFN-ks, IFN-ks related genes and the DEPDC5 gene in Hepatitis B virus-related liver disease.A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus.Role of immunoproteasome catalytic subunits in the immune response to hepatitis B virusAIC649 Induces a Bi-Phasic Treatment Response in the Woodchuck Model of Chronic Hepatitis B.Hepatitis B virus nucleocapsid but not free core antigen controls viral clearance in mice.Signal transduction pathways that inhibit hepatitis B virus replication.Molecular virology of hepatitis B virus for clinicians.Pegylated interferon α enhances recovery of memory T cells in e antigen positive chronic hepatitis B patientsImmune modulation by helminthic infections: worms and viral infections.Immunopathogenesis of hepatitis B virus infection.The alkylated imino sugar, n-(n-Nonyl)-deoxygalactonojirimycin, reduces the amount of hepatitis B virus nucleocapsid in tissue culture.The role of tumour necrosis factor in hepatitis B infection: Jekyll and Hyde.Limited hepatitis B virus replication space in the chronically hepatitis C virus-infected liver.Hepatitis B virus infection: pathogenesis, reactivation and management in hematopoietic stem cell transplant recipients.Innate antiviral immune responses to hepatitis B virus.
P2860
Q24306639-C44DFA32-8E16-4B19-A1A5-967F3848AD22Q24681387-33C44E07-F703-46B3-ACF7-0EB121E6260AQ26771142-D7D88388-A0AF-4ACD-AE2F-1FDA3E1ECFDDQ26781795-94134ED4-105F-4FC2-A2DF-78F3FC288D3FQ27473045-E045B3E4-A8BE-411B-A93A-EAD61F27B71AQ27473083-0FB4FDC2-1578-483F-90A6-A3B61DF9F332Q28509475-C55D06AF-F1CB-4B15-B8B9-C236A45D2491Q29618957-FCB74149-B8DE-4E9B-9933-A19D22EAFF28Q33696514-5D112A47-7761-4268-A1FE-B9E5AB05BA05Q33930340-F6C4E355-2207-4902-863F-74C91387F029Q33987442-D56EF5C2-A1FF-4C5D-94F5-49BC7FBCF618Q34120253-4F442D3B-7911-4F0D-A88C-B9438002415CQ34123971-A4A745CB-59B9-431B-9B6B-5D73EE6AFF2BQ34137297-C72B6F2B-497F-4B7D-9642-ECA278358E65Q34140521-56CDCD76-9A9B-4B2F-BC7C-BA7566567F90Q34262302-36109FC9-7E0F-416E-B842-6A0FCD0B2929Q34279852-D878947D-2312-40F2-9742-1DF9D3DDBD34Q34465900-886A1C8D-8CF5-4533-95B0-256A0D57A3AAQ34488377-488C8952-8F4A-4988-AC40-D4818BC67D8EQ34599741-D832AAE5-744E-4314-9D7B-0CE4F07FEA9CQ34748063-90549AAC-5B47-4621-951F-E49723D5B00BQ34778619-0C22F28C-B08E-4630-A7F4-34A43C607904Q34853230-95494404-38E4-47A5-8337-40160F47593EQ35159158-2D754E63-C20D-4627-9FDD-208EEC7BE8E8Q35196596-5440F97C-AFAA-4AF8-9F56-F102B3414FDDQ35208006-3CDFEDF7-D0B6-48AF-9EFB-4D4DECA18D72Q35420938-A167B526-E600-4A1F-8634-E944799948B4Q35634949-E2CEE89F-0586-42A2-ABD9-EED4E2878B6BQ35866293-B9FC645F-A24E-4270-88CB-682781FAF371Q36154923-46601114-4128-4E47-8338-FD3D48820AFEQ36162240-8CC9741D-7032-48C1-9EC2-311976ECF14EQ36282234-5BAD3058-EAD4-4A25-855D-F8B413FE8DF5Q36455859-14C6A4BA-2636-48CC-9ACA-1ADBAEC33E5BQ36590684-A374FC1E-4D5D-4013-8F52-A06C851607F1Q36666336-5FBFF9C5-5139-4CF3-9CD6-A8FC37C53449Q36890738-C646DBFB-E6D3-429C-A908-BA523A7294DBQ37538505-41D2F0C7-09B1-4A74-B45C-318BF0934D9CQ37713973-91F7345D-29A5-4179-8B48-49158F850C4AQ37942651-08CA3EEF-BB1E-458C-A1E3-D63A6303580EQ37945209-347EED01-B14B-4B0B-9C83-43BBEEC999DD
P2860
Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Interferon-regulated pathways ...... eplication in transgenic mice.
@ast
Interferon-regulated pathways ...... eplication in transgenic mice.
@en
Interferon-regulated pathways ...... eplication in transgenic mice.
@nl
type
label
Interferon-regulated pathways ...... eplication in transgenic mice.
@ast
Interferon-regulated pathways ...... eplication in transgenic mice.
@en
Interferon-regulated pathways ...... eplication in transgenic mice.
@nl
prefLabel
Interferon-regulated pathways ...... eplication in transgenic mice.
@ast
Interferon-regulated pathways ...... eplication in transgenic mice.
@en
Interferon-regulated pathways ...... eplication in transgenic mice.
@nl
P2093
P2860
P50
P1433
P1476
Interferon-regulated pathways ...... replication in transgenic mice
@en
P2093
Amber Morris
Heike Mendez
P2860
P304
P356
10.1128/JVI.76.6.2617-2621.2002
P407
P577
2002-03-01T00:00:00Z